loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
chronic traumatic encephalopathy (cte), a degenerative brain disease, has been linked by medical researchers to the sort of hits football players endure.
.